WuXi AppTec, headquartered in Shanghai, China, supports customers across the full spectrum of drug R&D and manufacturing. Through its fully integrated CRDMO model — spanning every stage of drug development, a wide range of modalities, and a global footprint that stretches across Asia, Europe, and North America — the company enables seamless transitions and accelerates the path from idea to medicine. Although there is some overlap with other WuXi entities, WuXi AppTec focuses primarily on small molecule drugs, as well as cell and gene therapies.
